Jennifer Ciresi
@Redmile Group, Llc
Latest period2024 - Q3ReportedManaged Assets$1.697BTotal holdings63
Assets growth rate2.63%Assets growth rate (2-Q avg)-18.33%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Redmile Group, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.697B in assets, with a quarterly growth rate of 2.63% and a 2-quarter average growth rate of -18.33%. The portfolio is managed by Jennifer Ciresi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RGNXRegenxbio Inc
| 3.03% | $51.327M 4.893M shares@ $10.5 avg price | Increased 7.08% |
ADCTAdc Therapeutics Sa
| 2.91% | $49.358M 15.669M shares@ $3.16 avg price | Increased 2.62% |
FDMT4d Molecular Therapeutics In
| 0.81% | $13.643M 1.262M shares@ $10.82 avg price | Increased 17.58% |
ESTAEstablishment Labs Hldgs Inc
| 0.67% | $11.328M 261,803 shares@ $43.28 avg price | Increased 22.9% |